The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...
The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation by Dr. Laurence Klotz discussing initial perioperative outcomes of CAPTAIN, ...
A tumor is an abnormal mass of tissue that forms when cells grow and divide more than they should, or do not die when they should. Tumors may be benign ...
Independent.ie on MSN
‘It’s a way of giving back’ – meet the cancer survivor who now volunteers by driving patients to chemotherapy
A Dublin cancer survivor who has spent the last eight years driving cancer patients to and from their chemotherapy appointments has said it is his “form of payback” after his experience of the illness ...
AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Role of urinary exosomal FAM153C-RPL19 in detection and risk stratification of prostate cancer: A multicentre Chinese cohort study. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
The clinical impact of germline variants in DNA repair genes in patients who underwent curative surgery for localized prostate cancer. Multivariable logistic regression model for predicting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results